FACT- studiet (Febuxostat Allopurinol Controlled Trial) var et fase III, randomiseret, dobbeltblind, multicenterstudie over 52 uger.
The Febuxostat Allopurinol Controlled Trial (FACT) Study was a Phase 3, randomized, double-blind, multicenter, 52-week study.